F. Gary Toback
Corporate Officer/Principal bij The University of Chicago
Actieve functies van F. Gary Toback
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| The University of Chicago | Corporate Officer/Principal | 01-01-1985 | - |
Loopbaan van F. Gary Toback
Eerdere bekende functies van F. Gary Toback
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
NephRx Corp.
 NephRx Corp. BiotechnologyHealth Technology NephRx Corp. provides therapeutic products for the treatment of kidney failures. The firm's flagship product includes NX001 is a kidney growth factor peptide for acute renal failure that is currently in preclinical development for treatment of delayed graft function in transplant patients. The company was founded in 2001 by Pratik Shah and is headquartered in Kalamazoo, Michigan. | Hoofd Techniek/Wetenschap/O&O | - | - |
Opleiding van F. Gary Toback
| The Trustees of Columbia University in The City of New York | Undergraduate Degree |
| New York University | Doctorate Degree |
| Boston University | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
Operationeel
| Doctorate Degree | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Consumer Services | 5 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
NephRx Corp.
NephRx Corp. BiotechnologyHealth Technology NephRx Corp. provides therapeutic products for the treatment of kidney failures. The firm's flagship product includes NX001 is a kidney growth factor peptide for acute renal failure that is currently in preclinical development for treatment of delayed graft function in transplant patients. The company was founded in 2001 by Pratik Shah and is headquartered in Kalamazoo, Michigan. | Health Technology |
- Beurs
- Insiders
- F. Gary Toback
- Ervaring
